| 0 |
CENTRAL NERVOUS SYSTEM MASS |
10 |
0.1053 |
| 1 |
WALL MOTION SCORE INDEX ABNORMAL |
10 |
0.0909 |
| 2 |
AIRWAY REMODELLING |
10 |
0.0806 |
| 3 |
ATOPY |
10 |
0.0360 |
| 4 |
CARDIAC SEPTAL DEFECT |
10 |
0.0139 |
| 5 |
EOSINOPHILIC MYOCARDITIS |
10 |
0.0137 |
| 6 |
INTRANASAL HYPOAESTHESIA |
1 |
0.0106 |
| 7 |
MICROANGIOPATHY |
10 |
0.0106 |
| 8 |
PULMONARY ARTERY OCCLUSION |
1 |
0.0104 |
| 9 |
VOCAL CORD CYST |
1 |
0.0102 |
| 10 |
SKIN CANCER METASTATIC |
1 |
0.0101 |
| 11 |
INFUSION SITE SCAB |
1 |
0.0081 |
| 12 |
POST-TUSSIVE VOMITING |
1 |
0.0061 |
| 13 |
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS |
10 |
0.0049 |
| 14 |
EOSINOPHIL COUNT DECREASED |
10 |
0.0042 |
| 15 |
BLOOD IMMUNOGLOBULIN E INCREASED |
10 |
0.0041 |
| 16 |
DEVICE WIRELESS COMMUNICATION ISSUE |
1 |
0.0039 |
| 17 |
RESPIRATORY SYMPTOM |
10 |
0.0035 |
| 18 |
SMOKE SENSITIVITY |
1 |
0.0032 |
| 19 |
EOSINOPHILIC PNEUMONIA |
10 |
0.0032 |
| 20 |
VENTRICULAR HYPOKINESIA |
10 |
0.0031 |
| 21 |
VASCULAR DEVICE OCCLUSION |
1 |
0.0029 |
| 22 |
CHRONIC SINUSITIS |
10 |
0.0027 |
| 23 |
NSAID EXACERBATED RESPIRATORY DISEASE |
1 |
0.0026 |
| 24 |
INFUSION SITE SCAR |
1 |
0.0023 |
| 25 |
NASAL POLYPS |
11 |
0.0022 |
| 26 |
DEPENDENCE ON OXYGEN THERAPY |
1 |
0.0020 |
| 27 |
CORYNEBACTERIUM INFECTION |
1 |
0.0019 |
| 28 |
MANUFACTURING PRODUCT SHIPPING ISSUE |
1 |
0.0018 |
| 29 |
INFUSION SITE DISCHARGE |
3 |
0.0017 |
| 30 |
DIAPHRAGMATIC PARALYSIS |
1 |
0.0017 |
| 31 |
INFUSION SITE HAEMORRHAGE |
5 |
0.0015 |
| 32 |
NASAL OPERATION |
1 |
0.0015 |
| 33 |
SUTURE RELATED COMPLICATION |
1 |
0.0014 |
| 34 |
DEVICE ELECTRICAL FINDING |
1 |
0.0014 |
| 35 |
ANTIBODY TEST ABNORMAL |
1 |
0.0014 |
| 36 |
INFUSION SITE INFECTION |
3 |
0.0013 |
| 37 |
DEVICE INFUSION ISSUE |
3 |
0.0012 |
| 38 |
SCIATIC NERVE INJURY |
1 |
0.0012 |
| 39 |
GIANT CELL ARTERITIS |
1 |
0.0012 |
| 40 |
EOSINOPHIL COUNT INCREASED |
10 |
0.0012 |
| 41 |
ALLERGIC SINUSITIS |
1 |
0.0012 |
| 42 |
TERMINAL INSOMNIA |
2 |
0.0011 |
| 43 |
PRODUCT AFTER TASTE |
1 |
0.0010 |
| 44 |
INTENTIONAL MEDICAL DEVICE REMOVAL BY PATIENT |
1 |
0.0010 |
| 45 |
PRODUCT COATING ISSUE |
1 |
0.0010 |
| 46 |
INTERVERTEBRAL DISC COMPRESSION |
1 |
0.0010 |
| 47 |
SINUSITIS BACTERIAL |
1 |
0.0009 |
| 48 |
INFUSION SITE BRUISING |
2 |
0.0009 |
| 49 |
INFUSION SITE MASS |
1 |
0.0009 |
| 50 |
MIDDLE EAR EFFUSION |
2 |
0.0009 |
| 51 |
OBSTRUCTIVE AIRWAYS DISORDER |
10 |
0.0009 |
| 52 |
DIVERTICULUM INTESTINAL HAEMORRHAGIC |
2 |
0.0009 |
| 53 |
CARBON DIOXIDE DECREASED |
1 |
0.0009 |
| 54 |
TONGUE HAEMORRHAGE |
1 |
0.0009 |
| 55 |
INFUSION SITE WARMTH |
1 |
0.0008 |
| 56 |
NODULE |
10 |
0.0008 |
| 57 |
ABNORMAL SLEEP-RELATED EVENT |
1 |
0.0008 |
| 58 |
SUDDEN ONSET OF SLEEP |
1 |
0.0007 |
| 59 |
LYMPHOPENIA |
10 |
0.0007 |
| 60 |
INFUSION SITE PAIN |
9 |
0.0007 |
| 61 |
STEROID DIABETES |
1 |
0.0007 |
| 62 |
OBESITY |
10 |
0.0006 |
| 63 |
PULMONARY ARTERIAL PRESSURE INCREASED |
1 |
0.0006 |
| 64 |
INJECTION SITE INFECTION |
2 |
0.0006 |
| 65 |
TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED |
1 |
0.0006 |
| 66 |
INFUSION SITE ERYTHEMA |
5 |
0.0006 |
| 67 |
PATIENT DISSATISFACTION WITH TREATMENT |
1 |
0.0005 |
| 68 |
OCULAR HYPERTENSION |
1 |
0.0005 |
| 69 |
HYPOGEUSIA |
1 |
0.0005 |
| 70 |
SEASONAL ALLERGY |
7 |
0.0005 |
| 71 |
INFUSION SITE SWELLING |
3 |
0.0005 |
| 72 |
DEVICE CONNECTION ISSUE |
1 |
0.0005 |
| 73 |
PURULENT DISCHARGE |
2 |
0.0005 |
| 74 |
BLOOD LOSS ANAEMIA |
1 |
0.0004 |
| 75 |
VASCULAR DEVICE INFECTION |
2 |
0.0004 |
| 76 |
MENOPAUSAL SYMPTOMS |
1 |
0.0004 |
| 77 |
RESPIRATORY TRACT INFECTION VIRAL |
1 |
0.0004 |
| 78 |
SINUS PAIN |
1 |
0.0004 |
| 79 |
RESPIRATORY TRACT INFECTION |
11 |
0.0004 |
| 80 |
ANGLE CLOSURE GLAUCOMA |
1 |
0.0004 |
| 81 |
NASAL DISORDER |
1 |
0.0004 |
| 82 |
ANIMAL BITE |
1 |
0.0004 |
| 83 |
LACRIMATION INCREASED |
11 |
0.0004 |
| 84 |
DRUG TOLERANCE DECREASED |
1 |
0.0004 |
| 85 |
OXYGEN SATURATION ABNORMAL |
1 |
0.0004 |
| 86 |
DERMATITIS CONTACT |
4 |
0.0004 |
| 87 |
PSEUDOMONAS INFECTION |
3 |
0.0003 |
| 88 |
FOREIGN BODY IN THROAT |
1 |
0.0003 |
| 89 |
INFUSION SITE PRURITUS |
1 |
0.0003 |
| 90 |
POLYMYALGIA RHEUMATICA |
1 |
0.0003 |
| 91 |
VIRAL INFECTION |
10 |
0.0003 |
| 92 |
POSTOPERATIVE WOUND INFECTION |
2 |
0.0003 |
| 93 |
PRODUCTIVE COUGH |
14 |
0.0003 |
| 94 |
HAEMATURIA |
10 |
0.0003 |
| 95 |
HAEMORRHAGIC DIATHESIS |
1 |
0.0003 |
| 96 |
SKIN WEEPING |
1 |
0.0003 |
| 97 |
DEVICE KINK |
1 |
0.0003 |
| 98 |
PARANASAL SINUS HYPERSECRETION |
1 |
0.0003 |
| 99 |
BOWEL MOVEMENT IRREGULARITY |
2 |
0.0003 |
| 100 |
THYROID MASS |
1 |
0.0003 |
| 101 |
MULTIPLE ALLERGIES |
2 |
0.0003 |
| 102 |
FUNGAL SKIN INFECTION |
1 |
0.0002 |
| 103 |
TENSION HEADACHE |
1 |
0.0002 |
| 104 |
RHINITIS ALLERGIC |
1 |
0.0002 |
| 105 |
IRON DEFICIENCY |
1 |
0.0002 |
| 106 |
ABDOMINAL HERNIA |
1 |
0.0002 |
| 107 |
ARTHRITIS INFECTIVE |
1 |
0.0002 |
| 108 |
RENAL DISORDER |
10 |
0.0002 |
| 109 |
SARCOIDOSIS |
1 |
0.0002 |
| 110 |
GASTROINTESTINAL MOTILITY DISORDER |
1 |
0.0002 |
| 111 |
PRODUCT SIZE ISSUE |
1 |
0.0002 |
| 112 |
PRODUCT DELIVERY MECHANISM ISSUE |
1 |
0.0002 |
| 113 |
HYDROCEPHALUS |
1 |
0.0002 |
| 114 |
RALES |
1 |
0.0002 |
| 115 |
GASTROENTERITIS VIRAL |
3 |
0.0002 |
| 116 |
TYPE 1 DIABETES MELLITUS |
1 |
0.0002 |
| 117 |
NOCTURIA |
2 |
0.0002 |
| 118 |
CARPAL TUNNEL SYNDROME |
2 |
0.0001 |
| 119 |
ARTHROPOD BITE |
1 |
0.0001 |
| 120 |
HAEMORRHAGIC STROKE |
1 |
0.0001 |
| 121 |
PRODUCT USE COMPLAINT |
2 |
0.0001 |
| 122 |
SCIATICA |
2 |
0.0001 |
| 123 |
PROSTATE CANCER |
10 |
0.0001 |
| 124 |
ASTHMA |
14 |
0.0001 |
| 125 |
HYPERAESTHESIA |
1 |
0.0001 |
| 126 |
SENSATION OF FOREIGN BODY |
1 |
0.0001 |
| 127 |
SKIN SWELLING |
1 |
0.0001 |
| 128 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
1 |
0.0001 |
| 129 |
PURPURA |
1 |
0.0001 |
| 130 |
OROPHARYNGEAL DISCOMFORT |
1 |
0.0001 |
| 131 |
INCREASED TENDENCY TO BRUISE |
1 |
0.0001 |
| 132 |
IRON DEFICIENCY ANAEMIA |
1 |
0.0001 |
| 133 |
MIDDLE INSOMNIA |
2 |
0.0001 |
| 134 |
SPUTUM DISCOLOURED |
1 |
0.0001 |
| 135 |
PRODUCT PACKAGING ISSUE |
1 |
0.0001 |
| 136 |
POST PROCEDURAL COMPLICATION |
2 |
0.0001 |
| 137 |
DIZZINESS POSTURAL |
1 |
0.0001 |
| 138 |
AUTOIMMUNE DISORDER |
1 |
0.0001 |
| 139 |
SINUS DISORDER |
2 |
0.0001 |
| 140 |
LIMB DISCOMFORT |
3 |
0.0001 |
| 141 |
TEMPERATURE INTOLERANCE |
1 |
0.0001 |
| 142 |
TENDERNESS |
1 |
0.0001 |
| 143 |
HAEMORRHAGE |
10 |
0.0001 |
| 144 |
INJECTION SITE DISCOMFORT |
1 |
0.0001 |
| 145 |
HEREDITARY ANGIOEDEMA |
1 |
0.0001 |
| 146 |
PHARYNGITIS STREPTOCOCCAL |
1 |
0.0001 |
| 147 |
NEPHROPATHY TOXIC |
1 |
0.0001 |
| 148 |
REBOUND EFFECT |
1 |
0.0001 |
| 149 |
NEOPLASM |
1 |
0.0001 |
| 150 |
BLOOD IRON DECREASED |
1 |
0.0001 |
| 151 |
WRIST FRACTURE |
1 |
0.0001 |
| 152 |
BURSITIS |
1 |
0.0001 |
| 153 |
INTRAOCULAR PRESSURE INCREASED |
1 |
0.0001 |
| 154 |
ORAL CANDIDIASIS |
1 |
0.0001 |
| 155 |
TOOTH INFECTION |
1 |
0.0001 |
| 156 |
EAR INFECTION |
2 |
0.0001 |
| 157 |
SINUS CONGESTION |
1 |
0.0001 |
| 158 |
PALLOR |
2 |
0.0001 |
| 159 |
GINGIVAL BLEEDING |
1 |
0.0001 |
| 160 |
DEVICE MECHANICAL ISSUE |
1 |
0.0001 |
| 161 |
PERIPHERAL COLDNESS |
1 |
0.0001 |
| 162 |
MEMORY IMPAIRMENT |
10 |
0.0001 |
| 163 |
HUNGER |
1 |
0.0001 |
| 164 |
DEVICE LEAKAGE |
3 |
0.0001 |
| 165 |
COMPLICATION ASSOCIATED WITH DEVICE |
1 |
0.0001 |
| 166 |
THROAT IRRITATION |
3 |
0.0001 |
| 167 |
RESPIRATORY DISORDER |
2 |
0.0001 |
| 168 |
HYPOAESTHESIA ORAL |
1 |
0.0001 |
| 169 |
DEVICE FAILURE |
1 |
0.0001 |
| 170 |
INSURANCE ISSUE |
1 |
0.0001 |
| 171 |
MUSCULOSKELETAL CHEST PAIN |
1 |
0.0001 |
| 172 |
BRAIN FOG |
1 |
0.0001 |
| 173 |
CYANOSIS |
1 |
0.0001 |
| 174 |
RESPIRATORY TRACT CONGESTION |
1 |
0.0001 |
| 175 |
NIGHT SWEATS |
2 |
0.0001 |
| 176 |
CONFUSIONAL STATE |
10 |
0.0001 |
| 177 |
MULTIPLE FRACTURES |
1 |
0.0001 |
| 178 |
STAPHYLOCOCCAL INFECTION |
2 |
0.0001 |
| 179 |
PHOTOSENSITIVITY REACTION |
1 |
0.0001 |
| 180 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
1 |
0.0001 |
| 181 |
MUSCULOSKELETAL DISCOMFORT |
1 |
0.0001 |
| 182 |
DEVICE DEFECTIVE |
1 |
0.0001 |
| 183 |
HYPOXIA |
2 |
0.0001 |
| 184 |
DRUG ERUPTION |
1 |
0.0001 |
| 185 |
GOUT |
1 |
0.0001 |
| 186 |
OXYGEN SATURATION DECREASED |
3 |
0.0001 |
| 187 |
DYSPNOEA EXERTIONAL |
2 |
0.0001 |
| 188 |
FEELING JITTERY |
1 |
0.0001 |
| 189 |
ACUTE RESPIRATORY FAILURE |
1 |
0.0001 |
| 190 |
EAR PAIN |
1 |
0.0001 |
| 191 |
ORAL HERPES |
1 |
0.0001 |
| 192 |
WHEEZING |
3 |
0.0001 |
| 193 |
CATARACT |
3 |
0.0001 |
| 194 |
BLOOD PRESSURE ABNORMAL |
1 |
0.0001 |
| 195 |
FEEDING DISORDER |
1 |
0.0000 |
| 196 |
HYPERTENSION |
10 |
0.0000 |
| 197 |
IRRITABLE BOWEL SYNDROME |
1 |
0.0000 |
| 198 |
POOR QUALITY SLEEP |
1 |
0.0000 |
| 199 |
CLOSTRIDIUM DIFFICILE INFECTION |
1 |
0.0000 |
| 200 |
RASH PAPULAR |
1 |
0.0000 |
| 201 |
SNEEZING |
1 |
0.0000 |
| 202 |
THERAPY NON-RESPONDER |
2 |
0.0000 |
| 203 |
PRODUCT USE IN UNAPPROVED INDICATION |
11 |
0.0000 |
| 204 |
LOWER RESPIRATORY TRACT INFECTION |
2 |
0.0000 |
| 205 |
PRODUCT AVAILABILITY ISSUE |
1 |
0.0000 |
| 206 |
SHOCK |
1 |
0.0000 |
| 207 |
UPPER RESPIRATORY TRACT INFECTION |
2 |
0.0000 |
| 208 |
COUGH |
12 |
0.0000 |
| 209 |
LUNG DISORDER |
2 |
0.0000 |
| 210 |
AGEUSIA |
1 |
0.0000 |
| 211 |
UNEVALUABLE EVENT |
3 |
0.0000 |
| 212 |
GLYCOSYLATED HAEMOGLOBIN INCREASED |
1 |
0.0000 |
| 213 |
SINUSITIS |
4 |
0.0000 |
| 214 |
ILLNESS |
4 |
0.0000 |
| 215 |
SKIN ULCER |
1 |
0.0000 |
| 216 |
EXPOSURE VIA SKIN CONTACT |
1 |
0.0000 |
| 217 |
DEAFNESS |
1 |
0.0000 |
| 218 |
PNEUMONIA |
12 |
0.0000 |
| 219 |
CONDITION AGGRAVATED |
11 |
0.0000 |
| 220 |
DIVERTICULITIS |
1 |
0.0000 |
| 221 |
FEELING COLD |
1 |
0.0000 |
| 222 |
HAEMOPTYSIS |
1 |
0.0000 |
| 223 |
EYE PAIN |
2 |
0.0000 |
| 224 |
PAIN IN JAW |
1 |
0.0000 |
| 225 |
INTENTIONAL DOSE OMISSION |
1 |
0.0000 |
| 226 |
EYE IRRITATION |
2 |
0.0000 |
| 227 |
INFECTION |
5 |
0.0000 |
| 228 |
NEEDLE ISSUE |
1 |
0.0000 |
| 229 |
NASAL CONGESTION |
2 |
0.0000 |
| 230 |
BLOOD POTASSIUM DECREASED |
1 |
0.0000 |
| 231 |
CONTRAINDICATED PRODUCT ADMINISTERED |
1 |
0.0000 |
| 232 |
THERAPEUTIC RESPONSE DECREASED |
2 |
0.0000 |
| 233 |
HEAD INJURY |
1 |
0.0000 |
| 234 |
HYPOTHYROIDISM |
1 |
0.0000 |
| 235 |
MOVEMENT DISORDER |
1 |
0.0000 |
| 236 |
CHOLELITHIASIS |
1 |
0.0000 |
| 237 |
EYE DISORDER |
1 |
0.0000 |
| 238 |
HEART RATE INCREASED |
3 |
0.0000 |
| 239 |
THERAPEUTIC RESPONSE SHORTENED |
1 |
0.0000 |
| 240 |
VISUAL ACUITY REDUCED |
1 |
0.0000 |
| 241 |
DEHYDRATION |
4 |
0.0000 |
| 242 |
NEOPLASM MALIGNANT |
2 |
0.0000 |
| 243 |
TRANSIENT ISCHAEMIC ATTACK |
1 |
0.0000 |
| 244 |
CHEST DISCOMFORT |
3 |
0.0000 |
| 245 |
DEVICE USE ERROR |
1 |
0.0000 |
| 246 |
SLEEP DISORDER |
2 |
0.0000 |
| 247 |
DYSPNOEA |
16 |
0.0000 |
| 248 |
BRONCHITIS |
2 |
0.0000 |
| 249 |
HOT FLUSH |
2 |
0.0000 |
| 250 |
PARAESTHESIA |
4 |
0.0000 |
| 251 |
INJECTION SITE HAEMORRHAGE |
2 |
0.0000 |
| 252 |
HYPOTENSION |
5 |
0.0000 |
| 253 |
GASTROOESOPHAGEAL REFLUX DISEASE |
2 |
0.0000 |
| 254 |
EXTRA DOSE ADMINISTERED |
1 |
0.0000 |
| 255 |
PSORIATIC ARTHROPATHY |
1 |
0.0000 |
| 256 |
INFLUENZA LIKE ILLNESS |
2 |
0.0000 |
| 257 |
ROAD TRAFFIC ACCIDENT |
1 |
0.0000 |
| 258 |
DEVICE DISLOCATION |
1 |
0.0000 |
| 259 |
SEPTIC SHOCK |
1 |
0.0000 |
| 260 |
INJECTION SITE PAIN |
7 |
0.0000 |
| 261 |
COVID-19 |
4 |
0.0000 |
| 262 |
PULMONARY OEDEMA |
1 |
0.0000 |
| 263 |
GASTROINTESTINAL DISORDER |
2 |
0.0000 |
| 264 |
HYPOKALAEMIA |
1 |
0.0000 |
| 265 |
OROPHARYNGEAL PAIN |
2 |
0.0000 |
| 266 |
CHEST PAIN |
4 |
0.0000 |
| 267 |
BLOOD CHOLESTEROL INCREASED |
1 |
0.0000 |
| 268 |
ARRHYTHMIA |
1 |
0.0000 |
| 269 |
OCULAR HYPERAEMIA |
1 |
0.0000 |
| 270 |
DISEASE RECURRENCE |
1 |
0.0000 |
| 271 |
RASH ERYTHEMATOUS |
1 |
0.0000 |
| 272 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
1 |
0.0000 |
| 273 |
PRODUCT DOSE OMISSION ISSUE |
6 |
0.0000 |
| 274 |
CELLULITIS |
1 |
0.0000 |
| 275 |
BLOOD PRESSURE INCREASED |
3 |
0.0000 |
| 276 |
ECZEMA |
1 |
0.0000 |
| 277 |
WEIGHT INCREASED |
4 |
0.0000 |
| 278 |
RHEUMATOID ARTHRITIS |
2 |
0.0000 |
| 279 |
URINARY TRACT INFECTION |
3 |
0.0000 |
| 280 |
INCORRECT DOSE ADMINISTERED |
4 |
0.0000 |
| 281 |
PRODUCT SUBSTITUTION ISSUE |
1 |
0.0000 |
| 282 |
SEIZURE |
2 |
0.0000 |
| 283 |
SURGERY |
1 |
0.0000 |
| 284 |
OEDEMA PERIPHERAL |
2 |
0.0000 |
| 285 |
VERTIGO |
1 |
0.0000 |
| 286 |
NASOPHARYNGITIS |
3 |
0.0000 |
| 287 |
EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 288 |
LOSS OF CONSCIOUSNESS |
2 |
0.0000 |
| 289 |
RHINORRHOEA |
1 |
0.0000 |
| 290 |
PSORIASIS |
2 |
0.0000 |
| 291 |
FALL |
5 |
0.0000 |
| 292 |
SOMNOLENCE |
3 |
0.0000 |
| 293 |
HEPATIC ENZYME INCREASED |
1 |
0.0000 |
| 294 |
ERYTHEMA |
3 |
0.0000 |
| 295 |
ABDOMINAL PAIN UPPER |
3 |
0.0000 |
| 296 |
DEVICE MALFUNCTION |
1 |
0.0000 |
| 297 |
MOBILITY DECREASED |
1 |
0.0000 |
| 298 |
EPISTAXIS |
1 |
0.0000 |
| 299 |
HYPOAESTHESIA |
2 |
0.0000 |
| 300 |
DIABETES MELLITUS |
1 |
0.0000 |
| 301 |
INJECTION SITE SWELLING |
1 |
0.0000 |
| 302 |
PERIPHERAL SWELLING |
2 |
0.0000 |
| 303 |
BACK PAIN |
3 |
0.0000 |
| 304 |
DRUG DOSE OMISSION BY DEVICE |
1 |
0.0000 |
| 305 |
HEADACHE |
8 |
0.0000 |
| 306 |
ARTHRITIS |
1 |
0.0000 |
| 307 |
INJECTION SITE BRUISING |
1 |
0.0000 |
| 308 |
CARDIAC FAILURE CONGESTIVE |
1 |
0.0000 |
| 309 |
TREMOR |
2 |
0.0000 |
| 310 |
DIZZINESS |
6 |
0.0000 |
| 311 |
URTICARIA |
2 |
0.0000 |
| 312 |
ABDOMINAL DISCOMFORT |
2 |
0.0000 |
| 313 |
RENAL IMPAIRMENT |
1 |
0.0000 |
| 314 |
BALANCE DISORDER |
1 |
0.0000 |
| 315 |
FATIGUE |
9 |
0.0000 |
| 316 |
INTENTIONAL PRODUCT USE ISSUE |
1 |
0.0000 |
| 317 |
MUSCULOSKELETAL STIFFNESS |
1 |
0.0000 |
| 318 |
TACHYCARDIA |
1 |
0.0000 |
| 319 |
DEVICE ISSUE |
1 |
0.0000 |
| 320 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
2 |
0.0000 |
| 321 |
MUSCLE SPASMS |
2 |
0.0000 |
| 322 |
CARDIAC DISORDER |
1 |
0.0000 |
| 323 |
PRODUCT USE ISSUE |
2 |
0.0000 |
| 324 |
DYSPHAGIA |
1 |
0.0000 |
| 325 |
GAIT DISTURBANCE |
2 |
0.0000 |
| 326 |
PRURITUS |
4 |
0.0000 |
| 327 |
DRUG INTOLERANCE |
1 |
0.0000 |
| 328 |
ATRIAL FIBRILLATION |
1 |
0.0000 |
| 329 |
PAIN IN EXTREMITY |
3 |
0.0000 |
| 330 |
DYSPEPSIA |
1 |
0.0000 |
| 331 |
ACCIDENTAL EXPOSURE TO PRODUCT |
1 |
0.0000 |
| 332 |
ARTHRALGIA |
4 |
0.0000 |
| 333 |
ABDOMINAL DISTENSION |
1 |
0.0000 |
| 334 |
PLATELET COUNT DECREASED |
1 |
0.0000 |
| 335 |
INFLUENZA |
1 |
0.0000 |
| 336 |
THROMBOCYTOPENIA |
1 |
0.0000 |
| 337 |
PYREXIA |
3 |
0.0000 |
| 338 |
GENERAL PHYSICAL HEALTH DETERIORATION |
1 |
0.0000 |
| 339 |
DECREASED APPETITE |
2 |
0.0000 |
| 340 |
CHILLS |
1 |
0.0000 |
| 341 |
VISUAL IMPAIRMENT |
1 |
0.0000 |
| 342 |
DRY SKIN |
1 |
0.0000 |
| 343 |
WEIGHT DECREASED |
2 |
0.0000 |
| 344 |
RASH |
3 |
0.0000 |
| 345 |
MALAISE |
3 |
0.0000 |
| 346 |
DRUG INTERACTION |
1 |
0.0000 |
| 347 |
DRUG INEFFECTIVE |
8 |
0.0000 |
| 348 |
MYALGIA |
1 |
0.0000 |
| 349 |
NO ADVERSE EVENT |
1 |
0.0000 |
| 350 |
HYPERSENSITIVITY |
1 |
0.0000 |
| 351 |
ASTHENIA |
2 |
0.0000 |
| 352 |
BLOOD GLUCOSE INCREASED |
1 |
0.0000 |
| 353 |
ANAEMIA |
1 |
0.0000 |
| 354 |
ALOPECIA |
1 |
0.0000 |
| 355 |
NAUSEA |
4 |
0.0000 |
| 356 |
PAIN |
3 |
0.0000 |
| 357 |
INSOMNIA |
1 |
0.0000 |
| 358 |
OFF LABEL USE |
3 |
0.0000 |
| 359 |
DIARRHOEA |
2 |
0.0000 |
| 360 |
VOMITING |
1 |
0.0000 |
| 361 |
DEATH |
1 |
0.0000 |